Refractory B-Cell Lymphoma Clinical Trials

8 clinical trials for Refractory B-Cell Lymphoma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology — RECRUITING · PHASE1
• Study of CAR-T Therapy in Older Patients — RECRUITING
• Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma — RECRUITING · PHASE2
• PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies — OTHER · PHASE1
• Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma — OTHER · PHASE1
• Study of Anti-CD19 iCAR NK Cells in Relapsed and Refractory B Cell Lymphoma — OTHER · PHASE1
• Study of Anti-CD19/CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma — OTHER · PHASE1
• Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma — OTHER · PHASE1

Refine this search